Naturalendo Tech Co., Ltd.

Research Naturalendo Tech Co., Ltd. (168330.KQ) on Bullrun: market cap KRW 67.09B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 67.09B.

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18KRW 67.09Bn/an/an/a

Dividend history

About Naturalendo Tech Co., Ltd.

Naturalendo Tech Co., Ltd. engages in the research, development, manufacture, and sale of natural product new drugs, cosmetics, materials, food additives, and health functional food in South Korea. The company offers EstroG-100, a functional raw material for women's menopause; HabaNova, a diet material; YGF 251, a phyto height growth booster; NET 2401, a multiway sleep-wake cycle regulator; Stauntonia hexaphylla Fruit Extract, an anti-inflammatory superfood; Q.186 complex for improving male menopause;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Naturalendo Tech Co., Ltd.'s market cap?

Naturalendo Tech Co., Ltd.'s market capitalization is KRW 67.09B.

What does Naturalendo Tech Co., Ltd. do?

Naturalendo Tech Co., Ltd. engages in the research, development, manufacture, and sale of natural product new drugs, cosmetics, materials, food additives, and health functional food in South Korea. The company offers EstroG-100, a functional raw material for women's menopause; HabaNova, a diet material; YGF 251, a phyto height growth booster; NET 2401, a multiway sleep-wake cycle regulator; Stauntonia hexaphylla Fruit Extract, an anti-inflammatory superfood; Q.186 complex for improving male menopause; NET 1701, a ultimate men's prostate and urinary support; and Quercus acuta Thunb.